The global Point-of-Care Testing Market size was valued at USD 45.56 billion in 2022, and is projected to reach USD 75.57 billion by 2032 at a CAGR of 8.5% from 2022 to 2032. Point-of-care testing (POCT) is a medical diagnostic testing conducted near the patient or at the site of care delivery, without the need for transportation of samples to a central laboratory. POCT provides rapid results and helps in making immediate treatment decisions. The Point-of-Care Testing Market is expected to witness significant growth due to the increasing prevalence of infectious diseases, rise in the geriatric population, and the growing demand for decentralized and patient-centered healthcare. Additionally, technological advancements, such as the development of portable and handheld devices, are also driving Point-of-Care Testing Market growth. Read More: https://analyticsmarketresearch.com/reports/point-of-care-testing-market/76905/

https://www.databridgemarketresearch.com/reports/global-cardiac-point-of-care-testing-kits-market